These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20205920)

  • 1. Early detection of Varicella-Zoster virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report.
    Baiker A; Haase R; Eberle J; Vizoso Pinto MG; Pfrepper KI; Petrich A; Deml L; Campe H; Nitschko H; Jaeger G
    Virol J; 2010 Mar; 7():54. PubMed ID: 20205920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interpretation of varicella serology in pregnancy].
    von Hintzenstern J; Jahn G
    Geburtshilfe Frauenheilkd; 1988 Dec; 48(12):859-62. PubMed ID: 2853094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C
    Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
    Frey CR; Sharp MA; Min AS; Schmid DS; Loparev V; Arvin AM
    J Infect Dis; 2003 Jul; 188(1):40-52. PubMed ID: 12825169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of varicella-zoster virus (VZV)-specific antibodies in the early phase of varicella in immunocompromized children.
    Nyerges G; Mészner Z; Simon M
    Acta Microbiol Hung; 1983; 30(3-4):211-5. PubMed ID: 6326459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus.
    Vossen MT; Gent MR; Weel JF; de Jong MD; van Lier RA; Kuijpers TW
    J Infect Dis; 2004 Jul; 190(1):72-82. PubMed ID: 15195245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
    Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
    J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox.
    Vossen MT; Gent MR; Peters KM; Wertheim-van Dillen PM; Dolman KM; van Breda A; van Lier RA; Kuijpers TW
    J Clin Microbiol; 2005 Nov; 43(11):5614-21. PubMed ID: 16272494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.
    Hackett CB; Wall D; Fitzgerald SF; Rogers S; Kirby B
    Br J Dermatol; 2011 Jun; 164(6):1387-9. PubMed ID: 21410679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
    Chris Maple PA; Gray J; Brown K; Brown D
    J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
    Jenkins DE; Yasukawa LL; Bergen R; Benike C; Engleman EG; Arvin AM
    J Immunol; 1999 Jan; 162(1):560-7. PubMed ID: 9886433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary varicella-zoster virus infection--current knowledge, diagnostic and therapeutic approaches].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I
    Med Pregl; 2000; 53(5-6):272-6. PubMed ID: 11089369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
    Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
    Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.